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Candidate genesrleukin-1 (IL1) gene have been suggested to inﬂuence transcription of IL1A
(interleukin-1α) and IL1B (interleukin-1β) and thereby the pathophysiology of periodontitis. This case-
control association study on 415 northern European Caucasian patients with aggressive periodontitis (AgP)
and 874 healthy controls was conducted to examine 10 single-nucleotide polymorphisms (SNPs) in the genes
of the IL1 cluster for association with IL1A, IL1B, CKAP2L (cytoskeleton-associated protein 2-like), and IL1RN
(IL-1 receptor antagonist). The results do not support an association between variants in the IL1 gene cluster
and AgP. This case-control study had at least 95% power to detect genuine associations with variants carrying
relative risks of at least 1.5 for heterozygous carriers and 2.25 for homozygous carriers. Previous reports of an
association between IL1 promoter SNPs and periodontitis might reﬂect subpopulation effects and have to be
interpreted with care.
© 2008 Elsevier Inc. All rights reserved.Periodontitis (MIM 260950) is an inﬂammatory disease of the
supporting tissues of the teeth [1]. About 10–15% of the human
population will develop a severe form of destructive periodontal
disease. The pathophysiology of the disease is inﬂuenced by
microorganisms in the subgingival bioﬁlm, by acquired systemic
diseases that reduce or hamper an “optimal” host defense, and by
lifestyle factors including smoking. Individual differences in disease
progression vary largely and are often not predictable by currently
known mechanisms. Several studies in twins have shown that a
signiﬁcant part of the clinical variance in periodontitis may be
attributable to genetic factors. Concordance rates for periodontitis
were 0.38 for monozygotic (MZ) twins and 0.16 for dizygotic (DZ)
twins in a study of 4908 twin pairs that, however, was not controlled
for environmental and lifestyle factors, including smoking [2]. In a
study of 64 MZ and 53 DZ adult twin pairs, a maximum likelihood
estimation of genetic and other potential risk factors reported that
MZ twins were found to be more similar than DZ twins for all clinical
measures [3]. This study established that genetic variance deter-el.de (B. Grössner-Schreiber).
l rights reserved.mines severity and extent of disease. The heritability of adult
periodontitis was estimated at 50% and was unaltered by adjust-
ments for environmental factors, including smoking. Thus research
has been conducted to identify susceptibility genes for periodontitis
(for reviews see [4–6]).
Currently two main forms of periodontitis are clinically diffe-
rentiated; chronic periodontitis is the most prevalent form and is
considered to be a slow ongoing process. The early onset form
(juvenile, postjuvenile, postadolescent) is less prevalent, but shows
more rapid destruction at a relatively young age and is therefore
termed “aggressive periodontitis” (AgP). The prevalence of the
aggressive form of periodontitis is estimated at 0.1 to 1% in European
Caucasians [7]. For this form it is assumed that genetic factors play a
more important role in the susceptibility than for chronic adult
periodontitis [5]. In several family studies AgP was found to be
compatible with an autosomal recessive disorder [8–11]. Mapping of
a large kindred suggested a genetic etiology of nonsyndromic
prepubertal periodontitis with a missense mutation in CTSC
(cathepsin C) as the disease gene (11q14) [12]. Cathepsin C
mutations have recently been identiﬁed as the genetic basis for
Papillon-Lefèvre syndrome [13,14]. Localized AgP has been described
Table 2
Single-nucleotide polymorphisms in the IL1A, IL1B, IL1RN, and CKAP2L genes analyzed
in the study population
SNP ID SNP name Position (NCBI_36) Locus Name Location Function
1 rs3811040 113,215,037 CKAP2L Exon Ser → Leu
2 rs4848298 113,229,975 CKAP2L Intron
3 rs17561 113,253,694 IL1A (+)4840 Exon Ser → Ala
4 rs3783526 113,258,278 IL1A Intron
5 rs3783525 113,258,290 IL1A Intron
6 rs2856837 113,258,396 IL1A Intron
7 rs1800587 113,259,191 IL1A (−)889 5′ UTR
8 rs1143634 113,306,861 IL1B (+)3954 Exon Synonymous
9 rs1143633 113,306,938 IL1B Intron
10 rs419598 113,603,678 IL1RN (+)2018 Exon Synonymous
310 A. Fiebig et al. / Genomics 92 (2008) 309–315in four African-American families with linkage to the chromosomal
locus 1q25 [15]. However, systematic association studies in large
patient samples are still lacking for AgP.
Various candidate geneshave been investigated for associationwith
periodontitis. Polymorphisms in the interleukin-1 (IL1) gene have been
suggested to inﬂuence transcription of IL1A and IL1B and thereby the
pathophysiology of periodontitis [16]. The proinﬂammatory cytokine
interleukin-1 (IL-1) is one of the key mediators of the inﬂammatory
process. IL-1 has the capacity to stimulate bone resorption and can
regulate ﬁbroblast cell proliferation of both gingival and periodontal
ligament origin [17,18]. In 1997, Kornman and colleagues [16] reported
that the combined presence of the R allele of the IL1A gene at
nucleotide position −889 and the R allele of the IL1B gene at nucleotide
position +3954 (also mentioned in the literature as +3953) was
associated with severity of periodontitis in nonsmoking Caucasian
patients. This combined carriage rate of theR alleleswasdesignated the
IL1 composite genotype [16]. Two other cross-sectional studies also
reported an association between the IL1 composite genotype and the
severity of periodontal destruction [19,20]. However, other studies
have failed to corroborate that the IL1 composite genotype alone may
behave as a risk factor for periodontitis severity [21–25]. In contrast to
the results of Kornman and colleagues [16], Meisel and colleagues
[24,25] observed the IL1 composite genotype to be associated with
periodontitis in smokers.
The genes encoding IL1A (113,259,442–113,247,963 bp) and IL1B
(113,310,827–113,330,808 bp) are located on the long arm of
chromosome 2, approximately 52 kb apart. They are located in a
cluster in high-level linkage disequilibrium with the genes for the IL-
1 receptor antagonist (IL1RN, 113,591,941–113,608,064 bp) and for
cytoskeleton-associated protein 2-like (CKAP2L, 113,238,657–
113,211,915 bp).
The aim of this study was to investigate genetic variants in the IL1
gene cluster for association with AgP in a large cohort of patients
(N=415) using a well-deﬁned and strong phenotype. The candidate
gene approach was supplemented by a haplotype analysis including
seven single-nucleotide polymorphisms (SNPs) in the IL1A and IL1B
genes, two SNPs in the neighboring gene CKAP2L, and one SNP in the
IL1RN gene.
Results
Study population and clinical ﬁndings
The case group consisted of 261 German and 154 Dutch patients.
Patients were required to show radiographically documented boneTable 1
Characteristics of patients with aggressive periodontitis (cases) and control subjects
Characteristic Cases (N=415) Controls (N=874)
Age at diagnosis 30.2±1.8 (16–35) 48.4±4.0 (18–77)
Geographic origin
German 261 (63%) 501 (57%)
Dutch 154 (37%) 373 (43%)
Gender
Male 138 (33%) 437 (50%)
Female 277 (67%) 437 (50%)
Smoking habit
Current or former smoker 290 (70%) 406 (46.5%)
Nonsmoker 120 (29%) 458 (52.4%)
Unknown status 5 (1%) 10 (1.1%)
Number of teeth
Total 28.2±1.4 (16–32) ND
With bone loss ≥50% 6.7±2.0 (2–32) ND
Cases (No. of teeth with bone loss ≥50%)
Group 1 (2 affected teeth) 82 (20%) -
Group 2 (3–6 affected teeth) 187 (45% -
Group 3 (≥7 teeth affected) 146 (35%) -
Values are given as means±standard deviations (range) or numbers (%) of subjects. ND,
not determined.loss of ≥50% at ≥2 teeth at an age ≤35 years. The mean age at the time
of diagnosis was 30.2 years (range 16–35), 67% were females (N=277;
Table 1). Two hundred ninety individuals were current or former
smokers, while 120 patients were nonsmokers. Five patients had an
unknown smoking status. The mean number of teeth in the cases was
28.2 (range 16–32), while the mean number of teeth with bone
loss ≥50% was 6.7 (range 2–28). Eighty-two patients had 2 affected
teeth, 187 patients had 3 to 6 teeth with bone loss ≥50%, and 146
patients were diagnosed with 7 or more teeth affected with severe
bone loss.
The total number of controls was 874, consisting of 501 German
and 373 Dutch individuals. The ratios of German to Dutch cases and
German to Dutch controls were almost equal. For the controls, the
ratio of male to femalewas 50/50. Themean agewas 48.4 years (range
18–77). In the control cohort 406 current and former smokers
participated in the study, 458 individuals were nonsmokers, and 10
had an unknown smoking status.
Prevalence of IL1 genotypes and alleles
Ten polymorphisms (Table 2) were genotyped (5 in the IL1A gene, 2
in the IL1B gene, 2 in the CKAP2L gene, and 1 in the IL1RN gene. All 10
assays had a call rate ≥95% and showed no signiﬁcant deviation from the
Hardy-Weinberg equilibrium in the control panel (Table 4). None of the
SNPs showed a statistically signiﬁcant difference in the genotype
frequencies between cases and controls (genotypic p values,
pCCG ≥0.1). For the allele distribution between cases and controls, two
SNPs, one in the gene IL1A (rs17561/+4840) and one in the gene IL1B
(rs1143634/+3954), showed a p valueb0.05, but the differences did not
reach the signiﬁcance level of b0.005 (rs17561, pCCA=0.0438, and
rs1143634, pCCA=0.0443). The ILRN SNP rs419598 (+2018; which is in
linkagewith IL1RN VNTR) and both CKAP2L SNPs revealed no signiﬁcant
genotypic or allelic differences between the patients and the healthy
controls. The combined genotypes of IL1A-ILB and the speciﬁc one ad
modum Kornman and colleagues [16], i.e., IL1A (rs1800587/-889) and
IL1B (rs1143634/+3954), showed no statistical signiﬁcance (for any of
the four identiﬁed haplotypes; all p valuesN0.05; Table 5).
Logistic regression analysis
All SNPs were tested for association under a dominant, a multi-
plicative, and a recessive model by using the likelihood-ratio test (LRT)
and theWald test with adjustment for the known risk factors smoking
and gender, both separately and combined. Results for both tests were
very similar; we therefore report only LRT p values. None of the tested
SNPs showed any signiﬁcant association for any of the models
(Table 6). Neither a subgroup analysis, which considered only cases
in groups 2 and 3 (see Table 1), nor the inclusion of an interaction term
genotyping-smoking status in the model altered these results (data
not shown). The two SNPs in the CKAP2L gene and the one SNP in the
IL1RN gene, when analyzed separately, showed no signiﬁcant
associations with disease.
Fig. 1. Linkage disequilibrium (LD) map for the genotyped SNPs of the IL1 gene cluster.
Three haploblocks were deﬁned (block 1, 2 SNPs in CKAP2L (1+2); block 2, 5 SNPs in
IL1A (3–7); block 3, 2 SNPs in IL1B (8+9). (A) LD block structure of 10 SNPs in cases.
Numbers in blocks present pairwise r2 values in cases (leading “0.” is omitted). (B) LD
block structure of 10 SNPs in controls. Numbers in blocks present pairwise r2 values in
controls (leading “0.” is omitted).
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LD structures as assessed by the squared correlation coefﬁcients
(r2) did not notably differ between cases and controls (Figs.1A and 1B).
In the 10 SNPs, three haplotype blocks were deﬁned following Gabriel
and colleagues [26] (Table 7). The ﬁrst block covered the 2 SNPs in
CKAP2L. The second block covered the 5 SNPs in IL1A and consisted
of three common haplotypes. Haplotype ACCCA had a higher
frequency in controls (0.312) than in cases (0.274), while haplotype
CAAAC was more common in cases (cases, 0.308; controls, 0.275). The
two genotyped SNPs in IL1B formed a third haplotype block.
Conﬁdence intervals (95%) overlapped for all haplotype frequencies
between cases and controls.
Power calculation
Under a multiplicative risk model with estimated relative risks of
1.5 and 2.25 for heterozygous and homozygous carriers, respectively,
our study had at least 95% power to detect genotyped susceptibility
alleles with frequencies≥0.25 at α=0.005 (for 10 markers). Power
would drop below 20% for relative risks of 1.2 and 1.44, respectively.
Discussion
This large case-control study does not support an association
between SNPs in the IL1 genes and aggressive periodontitis. None of
the 10 SNPs examined was statistically signiﬁcantly different in the
allelic or genotype frequencies between patients and controls. Also the
composite haplotype ad modum Kornman and colleagues [16] was not
different between these groups.Previous positive reports (see reviews [5,6,27]) employed small
sample sizes leading to a large potential for type 1 errors. Most
candidate gene studies of IL1A and/or IL1B were based on small
sample sizes ranging from 28 up to 132 Caucasian individuals with
AgP [20,28–32]. These genetic studies showed heterogeneity and
differences in patient selection (e.g., age, smokers and/or nonsmokers,
and diagnostic criteria used to deﬁne periodontal disease). The large
variation in case deﬁnitions is still one of the major problems
encountered in the interpretation of studies in relation to genetic
risk factors for periodontitis [33].
In our study both cases and controls were of Caucasian origin for at
least two generations. The combined analysis of Dutch and Germans
was based on the observed European allele frequencies reported by
Mueller and colleagues [34] and Krawczak and colleagues [35]. The
patient cohort studied here comprised relatively young patients with
a strong periodontitis phenotype (as evidenced by age and number of
affected teethwith bone loss). This means that the results of this study
are likely to be more reliable than studies including patients with a
less well deﬁned phenotype as one can expect a stronger contribution
of genetic factors. The logistic regression analysis was used to
minimize the effects of risk factors like smoking and gender that
could obscure a genetic risk association.
To date, the role of IL1 gene cluster polymorphisms in the risk
assessment for periodontal disease is controversial. Kornman and
colleagues [16] reported ﬁrst on polymorphisms for the IL1 genes in
relation to periodontitis. Since then several other studies have
generated conﬂicting results regarding the association of SNPs in the
IL1 cluster, in particular for the genotype ad modum Kornman and
colleagues [16] (IL1A (−889), IL1B (−511/+3954)), with risk and/or
severity of periodontitis (positive ﬁndings, e.g., [21,30,31,36];
negative reports, e.g., [37]; Tai and colleagues [38] for IL1A
(+4845) and IL1B (−511, +3954); [39,40]). Some of these studies
were conducted in other ethnicities (e.g., Chilean, Japanese).
Furthermore, population frequencies for the risk alleles investigated
vary between ethnicities [5], and established disease genes can also
be only phenotype-relevant within certain ethnicities. For example,
variants in NOD2 are causative for Crohn disease in Caucasians but
play no role in Asians, although clinical presentation of the disease is
identical [41].
Studies on the polymorphisms of the IL1RN gene gave conﬂicting
results. In Caucasians an association with periodontitis was reported
[24,31]. Parkhill and colleagues [30] observed an association between
a combination of an IL1RN polymorphism and the IL1B (+3954) N
allele and smoking with AgP. In the Japanese, a signiﬁcant association
was observed for the gene IL1RN and periodontitis [38]. We tested the
IL1RN SNP (rs419598 (+2018)), which is in high LD (HapMap data:
http://www.hapmap.org/), with the tandem repeat IL1RN VNTR in
individuals of European origin [42]. In our study this SNP showed no
associationwith AgP and did not show considerable LDwith any of the
other genotyped SNPs.
Variants in CKAP2L are in strong LD with the variants in IL1A in
European populations visible by analyzing HapMap data (http://www.
hapmap.org/). Two SNPs in CKAP2L (rs3811040 and rs4848298) were
additionally tested for association with periodontitis in our study.
These SNPs showed strong LD with each other, but not with the SNPs
in the neighboring IL1A. We analyzed the haplotype structure of the
10 genotyped SNPs to investigate further a potential association
between AgP and potentially rare genetic variants not genotyped in
the samples. However, the overall distribution of the haplotypes did
not differ signiﬁcantly between cases and controls.
It was reported that the combined presence of the R allele of the
IL1A gene at nucleotide position −889 and the R allele of the IL1B
gene at nucleotide position +3954 (3953), i.e., the IL1 composite
genotype ad modum Kornman and colleagues [16], was associated
with severity of periodontitis in nonsmoking Caucasian patients
(N=99) but without using a control population. Two other cross-
Table 3
Sequences of the TaqMan assays
SNP
ID
SNP name Name Type of
assay
Sequence
1 rs3811040 AoDa Design strand: TGATGTTATACTAGTTTCAGCAACT
[A/G]AAGAGTCAGAAGTAATCCCTGTGTA (forward)
2 rs4848298 AoDa Design strand: CCTGACCTAGTCTTCTTGATGGTCA
[A/G]TTTGCCTAATCATCTTAAGTTGCAA (forward)
3 rs17561 (+)4845 AoDa Design strand: ACATTGCTCAGGAAGCTAAAAGGTG
[A/C]TGACCTAGGCTTGATGATTTCTAAA (reverse)
4 rs3783526 AbDb F-P: 5′-TCATTTTGCTGATAAGGACTGATTCGT-3′
R-P: 5′-ACCCATGCCCTCATAGGAAAC-3′
VIC probe: 5′-TAGTTCTGCTGTCCCTC-3′
FAM probe:5'-TTCTGCCGTCCCTC-3'
5 rs3783525 AbDb F-P: 5′-CCTCCCTGGTTTGGTATGTGA-3′
R-P: 5′-CATGCCCTCATAGGAAACTAGTTCT-3′
VIC probe: 5′-CCCTCAGTATAACGAATC-3′
FAM probe: 5′-CCTCAGTAAAACGAATC-3′
6 rs2856837 AbDb F-P: 5′-TGTTTTCTCTCACATTGCCTTCTCT-3′
R-P: 5′-CAAACCAGGGAGGGACAAGA-3′
VIC probe: 5′-AAAGAAAGGAGAGGCTGTAG-3′
FAM probe: 5′-AAAGAAAGGAGAGACTGTAG-3′
7 rs1800587 (-)889 AoDa Design strand: GATTTTTACATATGAGCCTTCAATG
[A/G]TGTTGCCTGGTTACTATTATTAAAG (reverse)
8 rs1143634 (+)3954 AoDa Design strand: CATAAGCCTCGTTATCCCATGTGTC
[G/A]AAGAAGATAGGTTCTGAAATGTGGA
(forward)
9 rs1143633 AoDa Design strand: TGTCCTCCAAGAAATCAAATTTTGCC
[A/G]CCTCGCCTCACGAGGCCTGCCCTTC (reverse)
10 rs419598 (+)2018 AoDa Design strand: TATCTGAGGAACAACCAACTAGTTGC
[C/T]GGATACTTGCAAGGACCAAATGTCA (forward)
a AoD, Assay on Demand.
b AbD, Assay by Design.
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composite genotype and the severity of periodontal destruction
(chronic periodontitis, N=90 [19]; Papapanou and colleagues [20]
(N=132)). However, several other studies have failed to corroborate
that the IL1 composite genotype alone may behave as a risk factor for
periodontitis severity [21–25]. In contrast to the results of Kornman
and colleagues [16], Meisel and colleagues [24,25] observed the IL1
composite genotype to be associated with periodontitis in smokers.
Results of the haplotype analysis of the current study including all 10
SNPs showed that the 2 SNPs of the IL1 composite genotype
(rs1800587 (−889) and rs1143634 (+3954)) belonged to two differentTable 4
Results of the genotyping of the SNPs in the study population
SNP ID SNP namea pHWEb co MAFc co MAFc ca pCCAd p
1 rs3811040 0.343 0.48 0.49 0.642 0
2 rs4848298 0.435 0.48 0.49 0.667 0
3 rs17561 0.556 0.31 0.27 0.044 0
4 rs3783526 0.102 0.28 0.31 0.087 0
5 rs3783525 0.078 0.27 0.31 0.091 0
6 rs2856837 0.670 0.31 0.28 0.068 0
7 rs1800587 0.522 0.31 0.28 0.064 0
8 rs1143634 0.584 0.26 0.23 0.044 0
9 rs1143633 0.309 0.35 0.34 0.938 0
10 rs419598 0.918 0.27 0.29 0.237 0
co, controls; ca, cases.
a All assays had a call rate N95% and showed no signiﬁcant deviations from the Hardy-W
b p value of the Hardy-Weinberg equilibrium in the controls.
c MAF, minor allele frequency.
d p value of the case-control analysis for the alleles.
e p value of the case-control analysis for the genotypes.
f p value of the case-control analysis for the rare allele.
g Odds ratio of the rare allele.
h 95% conﬁdence interval for the odds ratio of the rare allele.
i p value of the case-control analysis for carriership of the common allele.
j Odds ratio of the common allele.
k 95% conﬁdence interval for the odds ratio of the common allele.haploblocks. Additionally, a combination analysis for the IL1 compo-
site genotype (rs1800587 (−889) and rs1143634 (+3954)) was
performed and frequencies for cases and controls showed no
signiﬁcant differences.
In conclusion, this study does not support the contention that the
tested variants in the IL1 gene cluster are associated with aggressive
periodontitis in Caucasians. However, the IL1 gene cluster comprises
nine genes (IL1A, IL1B, ILRN, CKAP2L, IL1F5, IL1F6, IL1F7, IL1F10, IL1RL2)
and other genes than the currently examined may have an association
with aggressive periodontitis. Likewise the functional IL-1 pathway is
much more complex than the genes located in the IL1 cluster and
most of these have not been examined in this study.
Materials and methods
Study population
A total of 415 unrelated patients with AgP were recruited through
the European Periodontal Genetics (EPG) Consortium and private
practices in Germany and The Netherlands. The EPG Consortium was
established in 2002 by the Department of Operative Dentistry and
Periodontology, University of Kiel, Germany; the Department of
Periodontology, Operative and Preventive Dentistry, University of
Bonn, Germany; and the Department of Periodontology, Academic
Center for Dentistry Amsterdam, The Netherlands. To reduce genetic
heterogeneity in the cohorts, patientswere required to have parents of
northern European origin. Informed written consent was obtained
from all subjects recruited into this study. Inclusion criteria were as
follows: patients had to be ≤35 years of age at the time of diagnosis,
and they needed to have ≥2 teeth with ≥50% periodontal bone loss
and a full-mouth set of periapical radiographs or a panoramic
radiograph of diagnostic quality available for periodontal bone
scoring. All aspects of the medical history and health status, smoking
habits (current or former smoker, nonsmoker, or smoking status
unknown), and ethnic background were recorded by a questionnaire.
Subjects with a history of diabetes, hepatitis, or HIV infection were
excluded from the study. The study was approved by each institute’s
own ethical review board (Medical Ethical Committee, Universities of
Kiel and Bonn, and Medical Ethical Committee, Academic Medical
Center, University of Amsterdam, The Netherlands).
A reference control group (N=874) was obtained through
anonymous blood donors of European Caucasian descent. The GermanCCGe pCCRf ORRg ORR confh pCCCi ORCj ORC confk
.170 0.522 0.92 0.71–1.19 0.146 0.82 0.62–1.07
.152 0.481 0.91 0.70–1.18 0.143 0.82 0.62–1.07
.124 0.100 0.82 0.65–1.04 0.095 1.44 0.94–2.22
.211 0.097 1.22 0.96–1.54 0.305 0.79 0.51–1.24
.218 0.106 1.21 0.96–1.53 0.283 0.78 0.50–1.22
.187 0.122 0.83 0.66–1.05 0.156 1.36 0.89–2.09
.159 0.150 0.84 0.66–1.06 0.098 1.44 0.93–2.21
.121 0.095 0.82 0.64–1.04 0.101 1.54 0.92–2.58
.939 0.931 1.01 0.80–1.28 0.762 1.06 0.73–1.55
.435 0.197 1.17 0.92–1.48 0.694 0.91 0.59–1.43
einberg equilibrium in the controls.
Table 5
Analysis of genotypes ad modum Kornman et al. [16] for IL1A (-889) (rs1800587) and
IL1B (-511/+3954) (rs1143634)
Haplotype Frequency in controls (95% CI) Frequency in cases (95% CI) χ2 p
TC 0.083 (0.070–0.096) 0.083 (0.064–0.103) 0.078 0.780
TT 0.230 (0.210–0.250) 0.192 (0.166–0.219) 3.464 0.063
CC 0.656 (0.633–0.678) 0.691 (0.659–0.722) 1.495 0.221
CT 0.032 (0.023–0.041) 0.034 (0.022–0.048) 0.363 0.547
CI, conﬁdence interval.
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POPGEN biobank [35]. They were randomly identiﬁed through
resident registration ofﬁces and were of German ancestry (all had
German parents). The Dutch control group included 373 individuals
who volunteered to donate blood at the national blood bank (Sanquin,
Amsterdam, The Netherlands). All Dutch controls had Dutch parents
of Caucasian origin. For all controls, information on the general health
and dental health status and the most evident background and risk
factors, i.e., age, gender, and smoking, were recorded. Individuals with
known history of periodontal disease or tooth loss due to periodontal
disease were not included as controls in this study. All German control
participants gave written informed consent prior to enrollment, and
the ethics committee of the University Hospital Schleswig-Holstein,
Campus Kiel, approved the study. All Dutch controls gave written
informed consent prior to enrollment via the blood bank, and the
study was approved by the review board of the blood bank.
The gender ratios and smoking status varied strongly in the
controls in comparison to the cases. To avoid any inﬂuence of these
objective differences, the preliminary data (Table 4) were veriﬁed
against stratiﬁcation by adjustment for gender and smoking with
logistic regression analyses (explained under Data and statistical
analysis). A summary of the characteristics of patients with AgP
(cases) and controls is presented in Table 1.
Data protection of private information such as the patient’s name
or address was ensured by using anonymized identiﬁers [35]. All
patients and blood donors donated 30 ml whole blood in three EDTA-
containing vacuum tubes for DNA extraction. All blood samples were
subsequently frozen and stored at −80 °C.
Clinical assessments
For all patients with AgP the total number of teeth was recorded.
Radiographs of all teeth were evaluated by calibrated examiners to
determine the approximal bone loss, using the cementoenamel
junction of the tooth and the tooth apex as reference points. Bone
loss at the worst approximal site per tooth was recorded, expressed as
a percentage of the total root length. In this way, for each patient the
number of teeth with bone loss ≥50% was tabulated. We divided
patients with AgP into three groups based on the number of affectedTable 6
Results of the logistic regression analyses, adjusting for smoking and gender
SNP ID SNP name Model pLRT OR (95% CI)
1 rs3811040 Rec 0.247 1.181 (0.890–1.563)
2 rs4848298 Dom 0.236 0.849 (0.649–1.114)
3 rs17561 Mul 0.133 1.155 (0.957–1.397)
4 rs3783526 Mul 0.378 0.916 (0.754–1.114)
5 rs3783525 Mul 0.381 0.917 (0.755–1.114)
6 rs2856837 Mul 0.181 0.880 (0.728–1.061)
7 rs1800587 Mul 0.194 1.133 (0.939–1.370)
8 rs1143634 Mul 0.121 0.855 (0.699–1.042)
9 rs1143633 Dom 0.687 1.052 (0.822–1.349)
10 rs419598 Rec 0.300 0.880 (0.691–1.121)
Dom, dominant; Mul, multiplicative; Rec, recessive; LRT, logistic regression test; CI,
conﬁdence interval.teeth (Table 1). To test the inﬂuence of the number of affected teeth on
the strength of the phenotype, a logistic regression analysis was
performed with and without group 1 (two affected teeth, i.e., two
teeth with bone loss ≥50%).
DNA isolation and genotyping
Genomic DNA was prepared from defrosted blood samples with
the Invisorb Blood Giga Kit (Invitec, Berlin, Germany). All DNA samples
were quality checked on an agarose gel. Mutations were assayed with
TaqMan (Applied Biosystems (ABI), Foster City, CA, USA) on an
automated platform [43]. In brief, genomic DNAwas arrayed and dried
on 96-well and 384-well plates. TaqMan PCR was set up with Genesis
pipetting robots (Tecan, Männedorf, Switzerland). Samples were
ampliﬁed with ABI 9700 PCR machines (ABI) and ﬂuorescence was
measured with ABI 7700 and ABI 7900 ﬂuorometers (ABI). TaqMan
consists of a single-tube PCR assay, which exploits the 5′ exonuclease
activity of DNA polymerase [44]. The assay includes two locus-speciﬁc
PCR primers that ﬂank the SNP of interest (F, forward, and R, reverse)
and two allele-speciﬁc oligonucleotide TaqMan probes (VIC and FAM
probe). ABI offers customers two different types of assays: Assay on
Demand and Assay by Design. The SNPs investigated and the primers
that were used are listed in Tables 2 and 3, 4, 5, 6, 7 respectively. For
all 10 assays the same PCR protocol was used: (a) activation of the
AmpliTaq Gold-95 °C,10 min,1 cycle; (b) denaturation step-95 °C,15 s,
45 cycles; (c) annealing, elongation, and nucleolytic cleavage of
hybridized probes-60 °C, 1 min, 45 cycles; (d) storage at 4 °C. For the
endpoint measurement we used the ABI Prism 7900 HT Sequence
Detection System. Allele calling was done manually to ensure high-
quality data. All process data were logged into, and administered by, a
database-driven laboratory information management system
(LIMS/3). More information is available at http://www.ikmb.uni-kiel.
de/research.html under “Bioinformatics” [45].
Data and statistical analysis
All polymorphisms were required to have a call rate of at least 95%
prior to inclusion in the analysis. Deviations from Hardy-Weinberg
equilibrium were tested in the control group by using an exact test
[46] and a type 1 error level of 0.05. The association with AgP was
examined for each marker by using HaploView 4.0 [47] and the
Genomizer Engine [45], an in-house tool that performs contingency
table tests for genotype and allele frequencies and also provides
empirical signiﬁcances for p values as well as conﬁdence intervals for
odds ratios through randomization and bootstrapping. Logistic
regressionwas used to test for phenotypic associationwhile adjusting
for effects of gender and smoking habits. The parameter age was not
included as a cofactor because all genotyped cases were below 35
years. Each SNP was considered under a dominant, multiplicative, and
recessive effect model. Likelihood-ratio testing as well as Wald tests
was applied. Only the p values for the most signiﬁcant model are
presented in Table 6.Table 7
Haplotypes in the three identiﬁed haploblocks (see Fig. 1)
Block Haplotype Frequency in controls
(95% CI)
Frequency in cases
(95% CI)
χ2 p
(1) CKAP2L AA 0.522 (0.499–0.545) 0.513 (0.478–0.549) 0.192 0.661
CC 0.476 (0.453–0.499) 0.487 (0.451–0.522) 0.270 0.603
(2) IL1A CCCAC 0.413 (0.390–0.435) 0.417 (0.382–0.452) 0.057 0.812
ACCCA 0.312 (0.290–0.334) 0.274 (0.243–0.304) 3.849 0.050
CAAAC 0.275 (0.255–0.296) 0.308 (0.277–0.337) 2.993 0.084
(3) IL1B AA 0.391 (0.368–0.414) 0.429 (0.398–0.463) 3.419 0.064
AC 0.347 (0.325–0.369) 0.344 (0.313–0.376) 0.016 0.900
CA 0.262 (0.241–0.283) 0.226 (0.199–0.255) 3.827 0.050
CI, conﬁdence interval.
314 A. Fiebig et al. / Genomics 92 (2008) 309–315Calculation of LD between markers and the deﬁnition of haplotype
blocks [26] were carried out using HaploView 4.0beta15 (Day Lab,
Broad Institute, Cambridge, MA, USA) and HaploHack 3.2.0. Haplotype
frequencies were estimated and haplotypic tests for phenotypic
association were carried out by using FamHap, release 16 [48].
FamHap implements an expectation-maximization algorithm for
frequency estimation and χ2 tests as well simulation procedures to
test for haplotypic association. Again, frequency conﬁdence intervals
were calculated by using nonparametric bootstrapping with 10,000
replications, implemented in Perl scripts.
Power analysis
For assessing the statistical power of our settings to reveal
potential genetic associations, we considered a multiplicative model
for each SNP. Disease prevalence was assumed to equal 1%, while the
locus allele frequency was assumed to equal 0.25, roughly corres-
ponding to the lower limit of the observedmarker allele frequencies in
the control group. Causative variants were assumed to be either
genotyped or perfectly correlated with a marker genotyped in this
study. Applying conservative Bonferroni correction, the signiﬁcance
level was set to α=0.005. Calculations were carried out using the
Genetic Power Calculator [49].
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